Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Do-Youn Oh
A Phase 3 Study of Nivolumab in Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (ATTRACTION-2): 2-Year Update Data
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Exploratory Subgroup Analysis of Patients With Prior Trastuzumab Use in the ATTRACTION-2 Trial: A Randomized Phase III Clinical Trial Investigating the Efficacy and Safety of Nivolumab in Patients With Advanced Gastric/Gastroesophageal Junction Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Metabolic Landscape of Advanced Gastric Cancer According to HER2 and Its Prognostic Implications
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients With Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary
Neuroendocrinology
Molecular Neuroscience
Endocrine
Endocrinology
Autonomic Systems
Cellular
Metabolism
Diabetes
Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Early Metabolic Response Using FDG PET/CT and Molecular Phenotypes of Breast Cancer Treated With Neoadjuvant Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients With Curatively Resected Ampulla of Vater Cancer
PLoS ONE
Multidisciplinary
1
2
›